Trial · NCT01886313
Adverse events28
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 28
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Application Site Burning | General disorders | Double Blind Treatment Period Civamide Nasal Spray | 3 | 6 | 11 |
| other | Application Site Burning | General disorders | Double Blind Treatment Period Placebo Nasal Spray | 1 | 5 | 1 |
| other | Application Site Irritation | General disorders | Double Blind Treatment Period Civamide Nasal Spray | 3 | 6 | 17 |
| other | Application Site Irritation | General disorders | Double Blind Treatment Period Placebo Nasal Spray | 0 | 5 | 0 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Double Blind Treatment Period Civamide Nasal Spray | 0 | 6 | 0 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Double Blind Treatment Period Placebo Nasal Spray | 2 | 5 | 3 |
| other | Sneezing | Respiratory, thoracic and mediastinal disorders | Double Blind Treatment Period Civamide Nasal Spray | 1 | 6 | 4 |
| other | Sneezing | Respiratory, thoracic and mediastinal disorders | Double Blind Treatment Period Placebo Nasal Spray | 0 | 5 | 0 |
| other | Throat Irritation | Respiratory, thoracic and mediastinal disorders | Double Blind Treatment Period Civamide Nasal Spray | 1 | 6 | 3 |
| other | Throat Irritation | Respiratory, thoracic and mediastinal disorders | Double Blind Treatment Period Placebo Nasal Spray | 0 | 5 | 0 |
| other | Dyspepsia | Gastrointestinal disorders | Double Blind Treatment Period Civamide Nasal Spray | 0 | 6 | 0 |
| other | Dyspepsia | Gastrointestinal disorders | Double Blind Treatment Period Placebo Nasal Spray | 1 | 5 | 1 |
| other | Neuralgia | Nervous system disorders | Double Blind Treatment Period Civamide Nasal Spray | 1 | 6 | 2 |
| other | Neuralgia | Nervous system disorders | Double Blind Treatment Period Placebo Nasal Spray | 0 | 5 | 0 |
| other | Sinus Headache | Nervous system disorders | Double Blind Treatment Period Civamide Nasal Spray | 0 | 6 | 0 |
| other | Sinus Headache | Nervous system disorders | Double Blind Treatment Period Placebo Nasal Spray | 1 | 5 | 1 |
| other | Limb Discomfort | Musculoskeletal and connective tissue disorders | Double Blind Treatment Period Civamide Nasal Spray | 1 | 6 | 1 |
| other | Limb Discomfort | Musculoskeletal and connective tissue disorders | Double Blind Treatment Period Placebo Nasal Spray | 0 | 5 | 0 |
| other | Pain in Extremity | Musculoskeletal and connective tissue disorders | Double Blind Treatment Period Civamide Nasal Spray | 1 | 6 | 1 |
| other | Pain in Extremity | Musculoskeletal and connective tissue disorders | Double Blind Treatment Period Placebo Nasal Spray | 0 | 5 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01886313/events